143 related articles for article (PubMed ID: 9038848)
21. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
[TBL] [Abstract][Full Text] [Related]
22. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
Dabroś W; Kordowiak AM; Dziga D; Gryboś R
Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409
[TBL] [Abstract][Full Text] [Related]
23. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
Kordowiak AM; Dziga D; Dabroś W
Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
[TBL] [Abstract][Full Text] [Related]
24. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
[TBL] [Abstract][Full Text] [Related]
25. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
26. Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats.
Sanchez-Gonzalez C; Bermudez-Peña C; Guerrero-Romero F; Trenzado CE; Montes-Bayon M; Sanz-Medel A; Llopis J
Br J Nutr; 2012 Sep; 108(5):893-9. PubMed ID: 22085676
[TBL] [Abstract][Full Text] [Related]
27. Reduction in hyperglycemia by mild food restriction in streptozotocin induced diabetic rats improves insulin sensitivity.
Cameron-Smith D; Collier GR; O'Dea K
Horm Metab Res; 1994 Jul; 26(7):316-21. PubMed ID: 7959606
[TBL] [Abstract][Full Text] [Related]
28. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
29. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
30. Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding.
Malabu UH; Dryden S; McCarthy HD; Kilpatrick A; Williams G
Diabetes; 1994 Jan; 43(1):9-15. PubMed ID: 8262323
[TBL] [Abstract][Full Text] [Related]
31. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
32. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
Cam MC; Brownsey RW; Rodrigues B; McNeill JH
Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
[TBL] [Abstract][Full Text] [Related]
33. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Cam MC; Rodrigues B; McNeill JH
Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
[TBL] [Abstract][Full Text] [Related]
34. Vanadium increases GLUT4 in diabetic rat skeletal muscle.
Mohammad A; Sharma V; McNeill JH
Mol Cell Biochem; 2002 Apr; 233(1-2):139-43. PubMed ID: 12083368
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.
Dabroś W; Dziga D; Gryboś R; Kordowiak AM
Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019
[TBL] [Abstract][Full Text] [Related]
36. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
37. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
38. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo.
Mohammad A; Wang J; McNeill JH
Mol Cell Biochem; 2002 Jan; 229(1-2):125-8. PubMed ID: 11936837
[TBL] [Abstract][Full Text] [Related]
39. Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques.
Iglesias-González T; Sánchez-González C; Montes-Bayón M; Llopis-González J; Sanz-Medel A
Anal Bioanal Chem; 2012 Jan; 402(1):277-85. PubMed ID: 21842199
[TBL] [Abstract][Full Text] [Related]
40. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
